Location History:
- Darmstadt, DE (2011)
- Frankfurt-am-Main, DE (2009 - 2017)
- Altendorf, CH (2020 - 2021)
Company Filing History:
3 out of 810 
1 out of 121 
1 out of 1,248 
Years Active: 2009-2021
Title: Innovations of Hermann Russ in Ocular Treatment
Introduction
Hermann Russ is a notable inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of ocular health, particularly in the treatment of glaucoma and age-related macular degeneration. With a total of 5 patents, his work has the potential to impact many lives.
Latest Patents
Hermann Russ's latest patents include innovative methods for the treatment of glaucoma and age-related macular degeneration using a peptide known as D-TRP-AIB. These methods focus on the prevention and treatment of ocular disorders by blocking the toxic effects of β-amyloid (Aβ) derivatives. His pharmaceutical compositions aim to provide effective prevention and treatment for these serious conditions.
Career Highlights
Throughout his career, Hermann Russ has worked with prominent organizations such as Ramot at Tel Aviv University Ltd. and Merck Patent Gesellschaft. His experience in these institutions has allowed him to develop groundbreaking solutions in the field of ocular health.
Collaborations
Hermann has collaborated with esteemed colleagues, including Gerd Bartoszyk and Frank Weber, to further advance his research and innovations.
Conclusion
Hermann Russ's contributions to ocular treatment through his innovative patents highlight his dedication to improving health outcomes. His work continues to pave the way for advancements in the treatment of glaucoma and age-related macular degeneration.